These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10071182)

  • 1. Gynecomastia with risperidone-fluoxetine combination.
    Benazzi F
    Pharmacopsychiatry; 1999 Jan; 32(1):41. PubMed ID: 10071182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
    Pratheesh PJ; Praharaj SK; Srivastava A
    Psychopharmacol Bull; 2011; 44(1):70-3. PubMed ID: 22506441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive symptoms with risperidone.
    Mahendran R
    J Clin Psychiatry; 1999 Apr; 60(4):261-3. PubMed ID: 10221290
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of non cognitive symptoms of Alzheimer's disease].
    Grau-Veciana JM
    Rev Neurol; 2006 Apr 16-30; 42(8):482-8. PubMed ID: 16625511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use.
    Caley CF
    Can J Psychiatry; 1998 Apr; 43(3):307-8. PubMed ID: 9561323
    [No Abstract]   [Full Text] [Related]  

  • 6. Gynaecomastia following treatment by fluoxetine.
    Boulenger A; Viseux V; Plantin-Eon I; Redon JY; Commegeille P; Plantin P
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):109. PubMed ID: 12602992
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
    Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression.
    Ostroff RB; Nelson JC
    J Clin Psychiatry; 1999 Apr; 60(4):256-9. PubMed ID: 10221288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Extrapyramidal side effects with low-dose risperidone.
    Pies R
    Can J Psychiatry; 1997 Oct; 42(8):881. PubMed ID: 9356779
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary retention caused after fluoxetine-risperidone combination.
    Bozikas V; Petrikis P; Karavatos A
    J Psychopharmacol; 2001 Jun; 15(2):142-3. PubMed ID: 11448089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
    Duggal HS; Kithas J
    Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolactogenic effects of risperidone in male patients--a preliminary study.
    Shiwach RS; Carmody TJ
    Acta Psychiatr Scand; 1998 Jul; 98(1):81-3. PubMed ID: 9696519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine.
    Levy E; Margolese HC; Sultan S; Chouinard G
    Can J Psychiatry; 2003 Nov; 48(10):709-10. PubMed ID: 14674056
    [No Abstract]   [Full Text] [Related]  

  • 15. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and clinical experience with risperidone.
    Love RC; Nelson MW
    Expert Opin Pharmacother; 2000 Dec; 1(7):1441-53. PubMed ID: 11249477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder.
    Coskun M; Zoroglu S
    J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):297-300. PubMed ID: 19519265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients.
    Bondolfi G; Eap CB; Bertschy G; Zullino D; Vermeulen A; Baumann P
    Pharmacopsychiatry; 2002 Mar; 35(2):50-6. PubMed ID: 11985287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.